News Hvsen Biotechnology Co., Ltd.

Equities

300871

CNE1000047H6

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-07-02 pm EDT			5-day change	1st Jan Change
9.71 ^CNY	-0.92%		-1.22%	-32.85%

Apr. 24	Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 03	Hvsen Biotechnology Co., Ltd. announced a financing transaction	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Hvsen Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 29 May 2024	May. 22	CI
Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for 2023	Apr. 24	CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 24	CI
Hvsen Biotechnology Co., Ltd. announced a financing transaction	Apr. 02	CI
Tech-Bank Food Co., Ltd. announced that it has received CNY 1.197979975 billion in funding from a group of investors	Dec. 28	CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-29	CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Certain A Shares of Hvsen Biotechnology Co., Ltd. are subject to a Lock-Up Agreement Ending on 24-AUG-2023.	23-08-23	CI
Hvsen Biotechnology Co., Ltd. Implements Cash Dividend of A Shares for 2022, Payable on 21 June 2023	23-06-15	CI
Hvsen Biotechnology Co., Ltd. Approves Cash Dividend for the Year 2022	23-05-18	CI
Hvsen Biotechnology Co., Ltd. Proposes Final Cash Dividend for the Year 2022	23-04-27	CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.	23-04-25	CI
Hvsen Biotechnology Co., Ltd.'s Equity Buyback announced on April 22, 2022, has expired with 2,389,050 shares, representing 1.44% for CNY 50.02 million.	23-04-20	CI
Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.	23-04-03	CI
Tranche Update on Hvsen Biotechnology Co., Ltd.'s Equity Buyback Plan announced on April 22, 2022.	23-01-03	CI
Hvsen Biotechnology Co., Ltd. Approves Board Appointments	22-12-12	CI
Hvsen Biotechnology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-25	CI
Hubei Huisheng Biotechnology Co., Ltd. announced that it expects to receive CNY 700 million in funding from Hvsen Biotechnology Co., Ltd.	22-10-24	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hvsen Biotechnology Co., Ltd.

Equities

300871

CNE1000047H6

Summary

Filters